Lutetium-177-PSMA-617 in low-volume hormone sensitive metastatic prostate cancer, a prospective pilot study. Prive BM, Peters SMB, Muselaers CHJ, van Oort IM, et al. Clin Cancer Res 2021 Apr 21. pii: 1078-0432.CCR-20-4298.

Read + Share

Amedeo Smart

Independent Medical Education

Prive BM, Peters SMB, Muselaers CHJ, van Oort IM, et al. Lutetium-177-PSMA-617 in low-volume hormone sensitive metastatic prostate cancer, a prospective pilot study. Clin Cancer Res 2021 Apr 21. pii: 1078-0432.CCR-20-4298.
PMID: 33883176